Loading...
•
Jun 30, 2021
Integra LifeSciences Q2 2021 Earnings Report
Reported second quarter results and raised full-year 2021 guidance.
Key Takeaways
Integra LifeSciences reported strong second-quarter results, exceeding forecasts with a 50.8% increase in revenues to $390.0 million and adjusted EPS of $0.79. The company is raising its full-year revenue and EPS guidance.
Revenues of $390.0 million increased 50.8% on a reported basis and 48.7% on an organic basis compared to the prior year.
GAAP earnings per diluted share of $0.41, compared to $(0.00) in the second quarter of 2020; adjusted earnings per diluted share of $0.79, compared to $0.33 in the prior year.
Cash flow from operations of $91.3 million increased 176% from the prior year.
Raising full-year 2021 revenue guidance by $15 million to a range of $1,540 million to $1,550 million and adjusted earnings per share to a range of $2.98 to $3.05.
Forward Guidance
The Company is raising its full-year 2021 revenue guidance by $15 million to a range of $1,540 million to $1,550 million from $1,525 million to $1,535 million. The Company is also raising its full-year 2021 adjusted earnings per share guidance to new range of $2.98 to $3.05, from its prior range of $2.86 to $2.93.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...